Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now

You can switch off notifications anytime using browser settings.

Combating Covid-19: Efforts on to develop vaccine in 1 year, will cost USD 2-3 billion, says Prof Raghavan

Copy URL

India is making efforts to develop vaccine to treat COVID-19 patients, which will cost USD 2-3 billion, said Prof K Vijay Raghavan, Principal Scientific Advisor (PSA) to the Government of India, on Thursday. Prof Raghavan, who was speaking at a press conference, said the vaccine is given to the normal population, not the sick people. "Hence it is necessary that it is properly tested and its quality and safety are ensured."

Have something to say? Post your comment

Other useful Links

Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service